Literature DB >> 11768239

Ets-1 is involved in transcriptional regulation of the chick inducible nitric oxide synthase gene in embryonic ventricular myocytes.

T Takahashi1, Y Sugishita, K Kinugawa, T Shimizu, A Yao, K Harada, H Matsui, R Nagai.   

Abstract

In order to elucidate roles of Ets family of transcription factors in transcriptional activation of inducible nitric oxide synthase (iNOS) genes, we analyzed the chick iNOS gene expression in cultured chick embryonic ventricular myocytes (CEVM). Deletional analysis and site-directed mutagenesis demonstrated that both the Ets/PEA3 site (-221 to -216 bp) and the kappaB site (-101 to -93 bp) of the 5'-flanking region of the chick iNOS gene were involved in the maximal activation of the lipopolysaccharide (LPS)-induced expression of the reporter (luciferase) gene, although the proximal kappaB site played the more essential role. Electrophoretic mobility shift assay revealed that LPS augmented the nuclear protein bindings to the Ets/PEA3 as well as kappaB motifs. Ets-1, one of the Ets proteins, was suggested to be bound to the Ets/PEA3 oligonucleotide. By Northern blot analysis, LPS was shown to induce iNOS mRNA in CEVM, along with a preceding increase in the levels of c-ets-1 mRNA. Ets-1 may be involved in the iNOS gene transcription in CEVM, presumably through interacting with the NF-kappaB.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11768239     DOI: 10.1023/a:1012781618109

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  39 in total

1.  NF-kappa B and GTP cyclohydrolase regulate cytokine-induced nitric oxide production by cardiac myocytes.

Authors:  C V Oddis; M S Finkel
Journal:  Am J Physiol       Date:  1996-05

2.  Direct preconditioning of cultured chick ventricular myocytes. Novel functions of cardiac adenosine A2a and A3 receptors.

Authors:  J Strickler; K A Jacobson; B T Liang
Journal:  J Clin Invest       Date:  1996-10-15       Impact factor: 14.808

3.  Regulation of the GnT-V promoter by transcription factor Ets-1 in various cancer cell lines.

Authors:  J H Ko; E Miyoshi; K Noda; A Ekuni; R Kang; Y Ikeda; N Taniguchi
Journal:  J Biol Chem       Date:  1999-08-13       Impact factor: 5.157

4.  Synergistic regulation of the human interleukin-12 p40 promoter by NFkappaB and Ets transcription factors in Epstein-Barr virus-transformed B cells and macrophages.

Authors:  G Gri; D Savio; G Trinchieri; X Ma
Journal:  J Biol Chem       Date:  1998-03-13       Impact factor: 5.157

5.  Differential expression of ets-1 and ets-2 proto-oncogenes during murine embryogenesis.

Authors:  I G Maroulakou; T S Papas; J E Green
Journal:  Oncogene       Date:  1994-06       Impact factor: 9.867

6.  Molecular cloning and expression of inducible nitric oxide synthase in chick embryonic ventricular myocytes.

Authors:  T Shimizu; K Kinugawa; Y Sugishita; K Sugishita; K Harada; H Matsui; O Kohmoto; T Serizawa; T Takahashi
Journal:  Cardiovasc Res       Date:  1998-05       Impact factor: 10.787

7.  Inducible nitric oxide synthase in cattle. Differential cytokine regulation of nitric oxide synthase in bovine and murine macrophages.

Authors:  H Adler; B Frech; M Thöny; H Pfister; E Peterhans; T W Jungi
Journal:  J Immunol       Date:  1995-05-01       Impact factor: 5.422

8.  Nitric oxide synthase activities in human myocardium.

Authors:  A J de Belder; M W Radomski; H J Why; P J Richardson; C A Bucknall; E Salas; J F Martin; S Moncada
Journal:  Lancet       Date:  1993-01-09       Impact factor: 79.321

9.  The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding sites.

Authors:  A Gutman; B Wasylyk
Journal:  EMBO J       Date:  1990-07       Impact factor: 11.598

10.  Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide.

Authors:  Q W Xie; R Whisnant; C Nathan
Journal:  J Exp Med       Date:  1993-06-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.